Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,953 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
Mori T, Makino H, Okubo T, Fujiwara Y, Sawada M, Kuroboshi H, Tsubamoto H, Murakoshi H, Motohashi T, Kitawaki J, Ito K. Mori T, et al. Among authors: makino h. J Obstet Gynaecol Res. 2019 Mar;45(3):671-678. doi: 10.1111/jog.13885. Epub 2018 Dec 21. J Obstet Gynaecol Res. 2019. PMID: 30575239 Clinical Trial.
Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.
Nakatsuka E, Sawada K, Nakamura K, Yoshimura A, Kinose Y, Kodama M, Hashimoto K, Mabuchi S, Makino H, Morii E, Yamaguchi Y, Yanase T, Itai A, Morishige KI, Kimura T. Nakatsuka E, et al. Among authors: makino h. Oncotarget. 2017 Sep 12;8(52):89887-89902. doi: 10.18632/oncotarget.20834. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163796 Free PMC article.
1,953 results